International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Pharmacogenetics Committee

PhG Haufroid ViceChair 150x200


Vincent Haufroid
Brussels, Belgium


Contact Us
Scientific Committees
Pharmacogenetics Committee

2017 19 PhG Picard Nicolas Vice chair 150x200


Nicholas Picard
Limoges, France

Background & Purpose of the Committee

  • To promote the knowledge about clinically relevant DNA testing to optimize drug therapy
  • To enhance the translation of research into clinical practice
  • To encourage discussions on the clinical relevance of specific pharmacogenetics tests, to encourage research into clinically important areas with respect to drug treatment
  • To encourage interaction between pharmacologist and toxicologist to promote “toxicogenetics”

Past Years' Activities Held/Committee Initiatives

  • Make proposal for IATDMCT PGx session in Foz Do Iguassu, Brazil, 2019
  • Propose/validate a (minimal) NGS panel to be used for pharmacogenetic applications in the field of TDM and CT (to be published in IATDMCT Compass)
  • Explore the need for updated PGx guidelines in immunosuppressive therapy
  • Informed members of IATDMCT on current discussions regarding PGx testing, on new potentially interesting pharmacogenetic markers, and the emergence of new technologies.
  • Represented IATDMCT in  IFCC, AACC, EFLM, IUPHAR and ESPT for initiatives on PGx.
  • Advised IATDMCT Rotterdam committee on scientific program regarding PGx